(Q52543145)

3 May 2018

title

Matrix metalloproteinases: potential therapeutic target in spinal cord injury. (English)

1 reference

3 May 2018

author name string

Y Duchossoy

series ordinal

1

1 reference

3 May 2018

S Arnaud

series ordinal

2

1 reference

3 May 2018

S Feldblum

series ordinal

3

1 reference

3 May 2018

publication date

1 April 2001

1 reference

3 May 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

3 May 2018

volume

39

1 reference

3 May 2018

issue

4

1 reference

3 May 2018

page(s)

362-367

1 reference

3 May 2018

Matrix metalloproteinases and diseases of the CNS.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Increased activity of matrix metalloproteinase-2 in human glial and neuronal cell lines treated with HIV-1 gp41 peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Secretory products of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

The blood-brain barrier: morphology, molecules, and neurothelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

Experimental spinal cord injury: Wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.057

21 January 2018

Identifiers

DOI

10.1515/CCLM.2001.057

1 reference

3 May 2018

1 reference

3 May 2018